(DX2K) Xtrackers FTSE 100 Short - Ratings and Ratios
Inverse, Swap, Daily, UCITS, Germany
Description: DX2K Xtrackers FTSE 100 Short
The Xtrackers FTSE100 Short Daily Swap UCITS ETF1C (XETRA:DX2K) is an inverse equity ETF that allows investors to profit from a decline in the FTSE 100 index. It is designed to provide a daily return that is inverse to the performance of the underlying index, making it a tool for traders seeking to hedge or speculate on market downturns.
From a technical analysis perspective, the ETF is currently trading at €3.31, slightly below its 20-day Simple Moving Average (SMA) of €3.37, indicating a potential bearish trend. The 50-day and 200-day SMAs are at €3.42 and €3.45, respectively, further suggesting a downward trajectory. The Average True Range (ATR) is 0.04, or 1.29%, indicating moderate volatility. Given these indicators, a potential trading strategy could involve closely monitoring the ETFs price action relative to its SMAs and adjusting positions accordingly.
Fundamentally, the ETF has €16.39 million in Assets Under Management (AUM), which is relatively modest. This could impact liquidity, potentially making it more challenging to enter or exit large positions without significantly affecting the price. However, it also indicates that the ETF is not overly popular, which could be a contrarian signal if investors believe the FTSE 100 is due for a decline.
Combining technical and fundamental insights, a forecast for DX2K could involve watching for a break below its current price level, potentially accelerating its decline towards the 52-week low of €3.31 or slightly below, given the inverse nature of the ETF and its current technical setup. Conversely, if the FTSE 100 index were to rally, DX2K would likely decline further, potentially testing its support levels. Traders should closely monitor the FTSE 100s performance and adjust their strategies on DX2K accordingly, considering both the technical indicators and the broader market context.
Investors should be cautious and consider their risk tolerance, as inverse ETFs like DX2K are generally suited for short-term trading strategies due to their daily rebalancing and potential for compounding errors over longer periods. Its also crucial to keep an eye on the ETFs tracking performance and fees, as these can erode returns over time.
Additional Sources for DX2K ETF
DX2K ETF Overview
Market Cap in USD | 19m |
Category | Trading - Leveraged/Inverse Equity |
TER | 0.50% |
IPO / Inception | 2008-06-02 |
DX2K ETF Ratings
Growth Rating | -51.9 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -28.9 |
Analysts | - |
Fair Price Momentum | 2.89 EUR |
Fair Price DCF | - |
DX2K Dividends
Currently no dividends paidDX2K Growth Ratios
Growth Correlation 3m | -95% |
Growth Correlation 12m | -47.4% |
Growth Correlation 5y | -77.9% |
CAGR 5y | -6.75% |
CAGR/Max DD 5y | -0.19 |
Sharpe Ratio 12m | -1.41 |
Alpha | -6.77 |
Beta | -0.338 |
Volatility | 11.18% |
Current Volume | 1k |
Average Volume 20d | 0.5k |
Stop Loss | 3.1 (-4%) |
As of July 12, 2025, the stock is trading at EUR 3.23 with a total of 1,000 shares traded.
Over the past week, the price has changed by -0.45%, over one month by -1.63%, over three months by -9.62% and over the past year by -5.72%.
No, based on ValueRay´s Analyses, Xtrackers FTSE 100 Short (XETRA:DX2K) is currently (July 2025) a stock to sell. It has a ValueRay Growth Rating of -51.94 and therefor a clear technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DX2K is around 2.89 EUR . This means that DX2K is currently overvalued and has a potential downside of -10.53%.
Xtrackers FTSE 100 Short has no consensus analysts rating.
According to our own proprietary Forecast Model, DX2K Xtrackers FTSE 100 Short will be worth about 3.1 in July 2026. The stock is currently trading at 3.23. This means that the stock has a potential downside of -3.41%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 3.1 | -3.4% |